Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis

Ganapathy, A., Nieves, J. W., Keaveny, T. M., & Cosman, F. (2023). Effects of four-year cyclic versus two-year daily teriparatide treatment on volumetric bone density and bone strength in postmenopausal women with osteoporosis. Bone, 167, 116618. https://doi.org/10.1016/j.bone.2022.116618
Authors:
Aravinda Ganapathy
Jeri W Nieves
Tony M Keaveny
Felicia Cosman
Affiliated Authors:
Aravinda Ganapathy
Jeri W Nieves
Felicia Cosman
Columbia Affiliation:
Subjects:
Bone Density Conservation Agents (MeSH)
Osteoporosis (MeSH)
Osteoporosis, Postmenopausal (MeSH)
Teriparatide (MeSH)
Author Keywords:
teriparatide
volumetric bone mineral density
bone strength
qct
elink
Publication Type:
Article
Unique ID:
10.1016/j.bone.2022.116618
PMID:
36410666
DOI:
10.1016/j.bone.2022.116618
Journal:
Bone
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record

Record Created: